J. Zahradnik

发表

Influenza: its control in persons and populations.

R. Couch, T. Cate, W. P. Glezen, 1986, The Journal of infectious diseases.

Effect of oligosaccharide chain length, exposed terminal group, and hapten loading on the antibody response of human adults and infants to vaccines consisting of Haemophilus influenzae type b capsular antigen unterminally coupled to the diphtheria protein CRM197.

E. C. Stein, M. Pichichero, R. Betts, 1989, Journal of immunology.

Clinical trials with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza vaccines in Los Angeles children.

P. Krause, J. Cherry, Y. Bryson, 1977, The Journal of infectious diseases.

A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. Recombinant Outer-Surface Protein A Lyme Disease Vaccine Study Consortium.

S. Malawista, P. Lavin, M. Klempner, 1998, The New England journal of medicine.

Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults.

D. Bernstein, S. Plotkin, M. Schleiss, 2002, The Journal of infectious diseases.

Immunity to Haemophilus influenzae type b in young adults: correlation of bactericidal and opsonizing activity of serum with antibody to polyribosylribitol phosphate and lipooligosaccharide before and after vaccination.

D. Musher, M. Apicella, T. Murphy, 1986, Journal of Infectious Diseases.

Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age.

J. Hendley, P. Brunell, C. Berkowitz, 1987, The Journal of pediatrics.

Class-specific human bactericidal antibodies to capsular and noncapsular surface antigens of Neisseria meningitidis.

C. Frasch, R. Dolin, J. Zahradnik, 1984, The Journal of infectious diseases.

Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants.

P. Brunell, M. Lepow, C. Berkowitz, 1987, The Journal of infectious diseases.

AUGMENTED ANTIBODY (Ab) RESPONSES IN INFANTS ADMINISTERED A NEW HAEMOPHILUS INFLUENZAE TYPE B CAPSULAR POLYSACCHARIDE (PRP) DIPHTHERIA TOXOID CONJUGATE VACCINE (PRP-D)

J. Zahradnik, L. Gordon, 1984, Pediatric Research.

Growth-inhibiting antibody responses of humans vaccinated with recombinant outer surface protein A or infected with Borrelia burgdorferi or both.

A. Barbour, C. Luke, J. Zahradnik, 2000, The Journal of infectious diseases.

Antibody response of adults to an aluminum hydroxide-adsorbed Neisseria meningitidis serotype 2b protein-group B polysaccharide vaccine.

C. Frasch, C. Tsai, J. Zahradnik, 1988, The Journal of infectious diseases.

Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections.

S. Kaplan, E. Mason, J. Zahradnik, 1988, The Journal of pediatrics.

A canarypox vector-expressing cytomegalovirus (CMV) phosphoprotein 65 induces long-lasting cytotoxic T cell responses in human CMV-seronegative subjects.

W. Cox, É. Gönczöl, S. Plotkin, 2001, The Journal of infectious diseases.

Clinical and serological responses following primary and booster immunization with Salmonella typhi Vi capsular polysaccharide vaccines.

W. Keitel, J. Robbins, J. Zahradnik, 1994, Vaccine.

Serum neutralizing antibody and lymphocyte transformation responses after influenza B virus infections

A. Frank, L. Taber, J. Zahradnik, 1983, Journal of clinical microbiology.

Adenovirus hepatitis in an immunosuppressed adult patient.

D. Porter, J. Zahradnik, G. Carmichael, 1979, American journal of clinical pathology.

Adenovirus infection in the immunocompromised patient.

D. Porter, J. Zahradnik, M. Spencer, 1980, The American journal of medicine.

Immune responses in serum and respiratory secretions following vaccination with a live cold‐recombinant (cr35) and inactivated a/ussr/77 (h1n1) influenza virus vaccine

T. Cate, J. Kasel, H. Six, 1983, Journal of medical virology.

Measles revaccination. Persistence and degree of antibody titer by type of immune response.

P. Krause, J. Cherry, R. Welliver, 1978, American journal of diseases of children.

Atypical measles acquired abroad. Foreign travel and pseudoexotic disease.

J. Cherry, G. Rachelefsky, J. Zahradnik, 1979, JAMA.

A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne).

W. Cox, S. Plotkin, S. Pincus, 1999, The Journal of infectious diseases.

Safety and immunogenicity of attenuated dengue virus vaccines (Aventis Pasteur) in human volunteers.

D. Vaughn, J. Saluzzo, B. Innis, 2001, Vaccine.

Influenza immunization in children and young adults: clinical reactions and total and IgM antibody responses after immunization with whole-virus or split-product influenza vaccines.

D. Bernstein, J. Cherry, J. Zahradnik, 1982, American journal of diseases of children.

An Emerging SARS-CoV-2 Mutant Evades Cellular Immunity and Increases Infectivity

G. Schreiber, Y. Matsuura, H. Nasser, 2021, SSRN Electronic Journal.

Human immune response to an aluminum hydroxide absorbedNeisseria meningitidis serotype 2b protein vaccine

C. Frasch, J. Zahradnik, 1986, Antonie van Leeuwenhoek.

Hepatitis B vaccine: immune responses in children from families with an HBsAg carrier.

F. Hollinger, J. Zahradnik, D. Heiberg, 1985, Vaccine.

Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months.

D. Bernstein, J. Cherry, J. Zahradnik, 1982, Pediatrics.

Adenovirus pneumonia.

J. Zahradnik, 1987, Seminars in respiratory infections.

Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology.

R. Couch, J. Gerin, J. Zahradnik, 1987, The Journal of infectious diseases.

IgM and IgG antibody responses after immunization of children with inactivated monovalent (A/New Jersey/76) and bivalent (A/New Jersey/76-A/Victoria/75) influenza virus vaccines.

P. Krause, J. Cherry, Y. Bryson, 1977, The Journal of infectious diseases.